2D-Discrete Fourier Transform: Generalization of the MIA-QSAR strategy in molecular modeling

Chemometrics and Intelligent Laboratory Systems

Volumn 143, Issue , 2015, Pages 79-84

  Barigye, Stephen J ^a   Freitas, Matheus P ^a  

^a FEDERAL UNIVERSITY OF LAVRAS   (Brazil)

Author keywords

2D Discrete Fourier Transform; Magnitude spectrum; MIA QSAR; Multivariate image

Indexed keywords

2,5 DIAMINOBENZOPHENONE DERIVATIVE; 4 PHENYLPYRROLOCARBAZOLE DERIVATIVE; BENZIMIDAZOLE DERIVATIVE; BENZOPHENONE DERIVATIVE; CARBAZOLE DERIVATIVE; UNCLASSIFIED DRUG;

ACCURACY; ANTIMALARIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIPROTOZOAL ACTIVITY; ARTICLE; CHEMICAL STRUCTURE; FOURIER TRANSFORMATION; IMAGE ANALYSIS; MOLECULAR MODEL; MULTIVARIATE ANALYSIS; MULTIVARIATE IMAGE ANALYSIS APPLIED TO QUANTITATIVE STRUCTURE ACTIVITY RELATIONSHIP; PRIORITY JOURNAL; PROCESS OPTIMIZATION; QUANTITATIVE ANALYSIS; STRUCTURE ACTIVITY RELATION; TRICHOMONICIDAL ACTIVITY; TWO DIMENSIONAL DISCRETE FOURIER TRANSFORM;

EID: 84924566100     PISSN: 01697439     EISSN: 18733239     Source Type: Journal    
DOI: 10.1016/j.chemolab.2015.02.020     Document Type: Article

References (41)

1. Freitas M.P., Brown S.D., Martins J.A. MIA-QSAR: a simple 2D image-based approach for quantitative structure-activity relationship analysis. J. Mol. Struct. 2005, 738:149-154.
2. Freitas M.P. MIA-QSAR modelling of anti-HIV-1 activities of some 2-amino-6-arylsulfonylbenzonitriles and their thio and sulfinyl congeners. Org. Biomol. Chem. 2006, 4:1154-1159.
3. Freitas M. A 2D image-based approach for modelling some glycogen synthase kinase 3 inhibitors. Med. Chem. Res. 2007, 16:461-467.
4. Antunes J.E., Freitas M.P., Rittner R. Bioactivities of a series of phosphodiesterase type 5 (PDE-5) inhibitors as modelled by MIA-QSAR. Eur. J. Med. Chem. 2008, 43:1632-1638.
5. Freitas M.P., da Cunha E.F.F., Ramalho T.C., Goodarzi M. Multimode methods applied on MIA descriptors in QSAR. Curr. Comput. Aided Drug Des. 2008, 4:273-282.
6. Goodarzi M., Freitas M.P. Augmented three-mode MIA-QSAR modeling for a series of anti-HIV-1 compounds. QSAR Comb. Sci. 2008, 27:1092-1097.
7. Bitencourt M., Freitas M.P. Bi- and multilinear PLS coupled to MIA-QSAR in the prediction of antifungal activities of some benzothiazole derivatives. Med. Chem. 2009, 5:79-86.
8. Goodarzi M., de Freitas M.P. MIA-QSAR modelling of activities of a series of AZT analogues: bi- and multilinear PLS regression. Mol. Simul. 2009, 36:267-272.
9. Goodarzi M., Freitas M.P. On the use of PLS and N-PLS in MIA-QSAR: azole antifungals. Chemom. Intell. Lab. Syst. 2009, 96:59-62.
10. Lloret G.R., Cunha Neto Á., Rittner R., Bitencourt M., Freitas M.P., Aquino N.S. Synthesis and rational design of anti-inflammatory compounds: N-phenyl-cyclohexenyl sulfonamide derivatives. J. Phys. Org. Chem. 2009, 22:1188-1192.
11. Goodarzi M., Freitas M.P. MIA-QSAR coupled to principal component analysis-adaptive neuro-fuzzy inference systems (PCA-ANFIS) for the modeling of the anti-HIV reverse transcriptase activities of TIBO derivatives. Eur. J. Med. Chem. 2010, 45:1352-1358.
12. Goodarzi M., Freitas M.P. MIA-QSAR coupled to different regression methods for the modeling of antimalarial activities of 2-aziridinyl and 2,3-bis-(aziridinyl)-1,4-naphtoquinonyl sulfate and acylate derivatives. Med. Chem. 2011, 7:645-654.
13. Silla J.M., Nunes C.A., Cormanich R.A., Guerreiro M.C., Ramalho T.C., Freitas M.P. MIA-QSPR and effect of variable selection on the modeling of kinetic parameters related to activities of modified peptides against dengue type 2. Chemom. Intell. Lab. Syst. 2011, 108:146-149.
14. Bitencourt M., Freitas M.P., Rittner R. The MIA-QSAR method for the prediction of bioactivities of possible acetylcholinesterase inhibitors. Arch. Pharm. 2012, 345:723-728.
15. Bitencourt M., Freitas M.P. MIA-QSAR evaluation of a series of sulfonylurea herbicides. Pest Manag. Sci. 2008, 64:800-807.
16. Goodarzi M., Freitas M.P., Ramalho T.C. Prediction of 13C chemical shifts in methoxyflavonol derivatives using MIA-QSPR. Spectrochim. Acta A 2009, 74:563-568.
17. Goodarzi M., Freitas M.P. PLS and N-PLS-based MIA-QSTR modelling of the acute toxicities of phenylsulphonyl carboxylates to Vibrio fischeri. Mol. Simul. 2010, 36:953-959.
18. Freitas M.R., Matias S.V.B.G., Macedo R.L.G., Freitas M.P., Venturin N. Augmented multivariate image analysis applied to quantitative structure-activity relationship modeling of the phytotoxicities of benzoxazinone herbicides and related compounds on problematic weeds. J. Agric. Food Chem. 2013, 61:8499-8503.
19. Nunes C.A., Freitas M.P. aug-MIA-QSPR on the modeling of sweetness values of disaccharide derivatives. LWT Food Sci. Technol. 2013, 51:405-408.
20. Freitas M.R., Barigye S.J., Freitas M.P. Coloured chemical image-based models for the prediction of soil sorption of herbicides. RSC Adv. 2015, 5:7547-7553.
21. Guimarães M.C., da Mota E.G., Silva D.G., Freitas M.P. aug-MIA-QSPR modelling of the toxicities of anilines and phenols to Vibrio fischeri and Pseudokirchneriella subcapitata. Chemom. Intell. Lab. Syst. 2014, 134:53-57.
22. Freitas M., Freitas M., Macedo R.G. Aug-MIA-QSPR modeling of the soil sorption of carboxylic acid herbicides. Bull. Environ. Contam. Toxicol. 2014, 93:489-492.
23. Nunes C.A., Freitas M.P. Introducing new dimensions in MIA-QSAR: a case for chemokine receptor inhibitors. Eur. J. Med. Chem. 2013, 62:297-300.
24. Nunes C.A., Freitas M.P. aug-MIA-QSAR modeling of antimicrobial activities and design of multi-target anilide derivatives. J. Microbiol. Methods 2013, 94:217-220.
25. Duarte M.H., Barigye S.J., Freitas M.P. Exploring MIA-QSAR's for antimalarial quinolon-4(1H)-imines. Comb. Chem. High Throughput Screen. 2015, 18:208-216.
26. Fourier J.B.J. Théorie analytique de la chaleur 1822, Chez Firmin Didot, père et fils, Paris, France.
27. Gonzalez R.C., Woods R.E. Digital Image Processing 2007, Prentice Hall, Upper Saddle River, NJ. 3rd ed.
28. Dougherty E.R. Digital Image Processing Methods 1994, CRC Press, Boca Raton, FL.
29. Geladi P. Some special topics in multivariate image analysis. Chemom. Intell. Lab. Syst. 1992, 14:375-390.
30. Cormanich R.A., Freitas M.P., Rittner R. 2D chemical drawings correlate to bioactivities: MIA-QSAR modelling of antimalarial activities of 2, 5-diaminobenzophenone derivatives. J. Braz. Chem. Soc. 2011, 22:637-642.
31. Cormanich R.A., Goodarzi M., Freitas M.P. Improvement of multivariate image analysis applied to quantitative structure-activity relationship (QSAR) analysis by using wavelet-principal component analysis ranking variable selection and least-squares support vector machine regression: QSAR study of checkpoint kinase WEE1 inhibitors. Chem. Biol. Drug Des. 2009, 73:244-252.
32. Cormanich R.A., Nunes C.A., Freitas M.P. Desenhos de Estruturas Químicas Correlacionam-se com Propriedades Biológicas: MIA-QSAR. Quim. Nova 2012, 35:1157-1163.
33. MATLAB The MathWorks Inc. 2010, (Natick, Massachusetts).
34. Golbraikh A., Tropsha A. Beware of q2!. J. Mol. Graph. Model. 2002, 20:269-276.
35. Melagraki G., Afantitis A. Enalos KNIME nodes: exploring corrosion inhibition of steel in acidic medium. Chemom. Intell. Lab. Syst. 2013, 123:9-14.
36. Pratim Roy P., Paul S., Mitra I., Roy K. On two novel parameters for validation of predictive QSAR models. Molecules 2009, 14:1660-1701.
37. Zhang S., Golbraikh A., Oloff S., Kohn H., Tropsha A. A novel automated lazy learning QSAR (ALL-QSAR) approach: method development, applications, and virtual screening of chemical databases using validated ALL-QSAR models. J. Chem. Inf. Model. 2006, 46:1984-1995.
38. Melagraki G., Afantitis A. Enalos InSilicoNano platform: an online decision support tool for the design and virtual screening of nanoparticles. RSC Adv. 2014, 4:50713-50725.
39. Nunes C.A., Freitas M.P., Pinheiro A.C.M., Bastos S.C. Chemoface: a novel free user-friendly interface for chemometrics. J. Braz. Chem. Soc. 2012, 23:2003-2010.
40. Xie A., Sivaprakasam P., Doerksen R.J. 3D-QSAR analysis of antimalarial farnesyltransferase inhibitors based on a 2, 5-diaminobenzophenone scaffold. Bioorg. Med. Chem. 2006, 14:7311-7323.
41. Yi P., Fang X., Qiu M. 3D-QSAR studies of Checkpoint Kinase WEE1 inhibitors based on molecular docking, CoMFA and CoMSIA. Eur. J. Med. Chem. 2008, 43:925-938.